Latest study results on PARP inhibitor iniparib disappointing, but may be helpful in second-line therapy.
All News
All series
All All News
Advertisement
Biomarker research might reveal neuropathy risk with certain cancer therapies.
HPV-positive oral cancers are on the rise.
Avastin appears to reduce relative risk of disease progression in recurring ovarian cancer.
New cancer cell-trapping method could result in improved treatment.
CURE's Lena Huang sits down with actress Cynthia Nixon to discuss how cancer has affected her life.
Advertisement
Advertisement
Trending on CURE
1
FDA Approves Pimicotinib for Tenosynovial Giant Cell Tumor
2
Neuroendocrine Tumors: 7 Questions Patients Ask, Answered
3
Why Rituxan Plus Cladribine May Delay Hairy Cell Leukemia Relapse
4
Datroway Slows Brain Metastases in Triple-Negative Breast Cancer
5